“…NRVMs were centrifuged at 990 g at 4°C for 10 min, and cell pellets were resuspended in Dulbecco's modified Eagle's medium ϩ Glu-taMAX (10565-042; ThermoFisher), supplemented with 5% horse serum (16050 -122; ThermoFisher), pyruvic acid (3 mM, P-8574; Sigma), bovine serum albumin (2 g/L, A-7030; Sigma), ampicillin (100 g/mL, A-0166; Sigma), 100ϫ insulin-transferrin-selenium (41400045; ThermoFisher), antibiotic/antimycotic (1%, 15240062; ThermoFisher), linoleic acid (5 g/mL, L5900; Sigma), and ascorbic acid (100 M, Sigma; A4544), and then preplated to remove fibroblasts (2 ϫ 30 min, 37°C, 5% CO 2). Purified NRVMs were seeded on MEAs precoated with fibronectin (10 g/mL, F2006; Sigma) by either coating the whole MEA well (1 mL at 1,400,000 cells/mL, final density of 500,000 cells/cm 2 ) or only the central recording matrix with a 75 l droplet of 300,000 NRVMs. To ensure stable droplet formation critical to establishing a confluent cardiomyocyte monolayer, MEA hydrophobicity was increased by heating to 70°C for Ն2 h before seeding.…”